Assertio Therapeutics, Inc. buy PlusUltra
Start price
13.03.20
/
50%
€0.71
Target price
22.05.20
€3.00
Performance (%)
2.13%
End price
22.05.20
-
Summary
This prediction ended on 22.05.20 with a price of -. With a performance of 2.13%, the BUY prediction by PlusUltra for Assertio Therapeutics, Inc. closed with a slight gain. PlusUltra has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Assertio Therapeutics, Inc. | -2.667% | -2.667% | -87.813% | -92.074% |
iShares Core DAX® | 2.722% | -4.863% | 12.025% | 9.678% |
iShares Nasdaq 100 | 4.546% | -7.240% | 26.309% | 36.290% |
iShares Nikkei 225® | 6.353% | -6.674% | 10.125% | 4.745% |
iShares S&P 500 | 3.194% | -3.832% | 22.640% | 35.492% |
Comments by PlusUltra for this prediction
In the thread Discuss Assertio Therapeutics, Inc.
Buy with target price 3.0